Venky's (India) Limited has informed the Exchange about Transcript
VENKEYS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venky's reported a weak Q4 FY25, with Poultry segment EBITDA crashing from INR 38 crores to INR 4 crores, mainly blamed on the 30–45 day Kumbh Mela disrupting consumption, transport, and realisation in northern India. For the full year, Poultry revenue grew to INR 1,927 crores (vs INR 1,755 crores) and the Animal Health Products (AHP) segment rose 9% to INR 339 crores, while the Oil Seed segment showed early signs of recovery. The SPF egg export business nearly tripled to INR 20 crores (vs INR 7 crores) and a INR 70 crore capacity expansion is underway. Company debt stood at INR 165.14 crores (vs INR 167.51 crores) and group-company receivables came down sharply from INR 665 crores to INR 500 crores. Management guides for 5–10% poultry volume growth, ~25% growth in soybean volumes, and 25–30% growth in e-commerce/retail processed chicken sales in FY26.
Q4 weakness appears largely behind the stock as Kumbh disruptions fade, but FY26 performance remains sensitive to maize and soya prices plus poultry realisation trends. AHP margin expansion, SPF export scaling, and processed chicken growth are the key positive triggers to watch; however, the Oil Seed segment may not return to peak profitability soon, and management sidestepped questions on US chicken-leg imports and several segmental revenue splits.